Zobrazeno 1 - 5 of 5 pro vyhledávání: '"FOR THE GAP STUDY GROUP"'
2
Gemcitabine or Abraxane Combined with cisPlatin (GAP) as First-Line Treatment in Patients with Metastatic Triple-Negative Breast Cancer: A Multicenter, Randomized, Open-Label, Phase 3 Trial
Autor: Biyun Wang, Tao Sun, Yannan Zhao, Shusen Wang, Jian Zhang, Zhonghua Wang, Yue-E Teng, Li Cai, Min Yan, Xiaojia Wang, Zefei Jiang, Yueyin Pan, Jianfeng Luo, Zhimin Shao, Jiong Wu, Xiaomao Guo, Xi-Chun Hu, The GAP Study Group
Publikováno v: SSRN Electronic Journal.
Background: Platinum is recommended in combination with gemcitabine in the treatment of metastatic triple-negative breast cancer (mTNBC), such as carboplatin plus gemcitabine and cisplatin plus gemcitabine. However, an optimal partner with cisplatin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84e6992f28610590fd9812e8425b82a3
https://doi.org/10.2139/ssrn.3705293
Zobrazit plný text záznamu
3
Topography of geographic atrophy in age-related macular degeneration
Autor: Mauschitz, Mm, Fonseca, S, Chang, P, Göbel, Ap, Fleckenstein, M, Jaffe, Gj, Holz, Fg, Schmitz Valckenberg, S, Midena, Edoardo, GAP Study Group
Publikováno v: Investigative ophthalmologyvisual science. 53(8)
PURPOSE: To determine the topographic distribution and progression of geographic atrophy (GA) in patients with AMD. METHODS: Fundus autofluorescence images (excitation 488, emission 500-700 nm) from 413 eyes of 413 subjects (median age, 77.0 years; i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d1783216799c69fd2f1ed7e699579e2
https://pubmed.ncbi.nlm.nih.gov/22661483
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje